Agilon Health AGL Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months) at other companies
Other financials
Where this comes from
Reported directly by Agilon Health in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger.
The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agilon Health's available-for-sale debt securities - unrealized loss position (>=12 months).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agilon Health's available-for-sale debt securities - unrealized loss position (>=12 months)?
- Agilon Health (AGL) reported available-for-sale debt securities - unrealized loss position (>=12 months) of $0 in Q4 2025.
- How has Agilon Health's available-for-sale debt securities - unrealized loss position (>=12 months) changed year-over-year?
- Agilon Health's available-for-sale debt securities - unrealized loss position (>=12 months) decreased by 100.0% year-over-year, from $111.92M to $0.
- What is the long-term trend for Agilon Health's available-for-sale debt securities - unrealized loss position (>=12 months)?
- Over 2 years (2023 to 2025), Agilon Health's available-for-sale debt securities - unrealized loss position (>=12 months) has grown at a -100.0% compound annual growth rate (CAGR), from $202.17M to $0.